Latest news
Filters (1)
November 9, 2021
Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…
Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…